GLP-1 medications like semaglutide and tirzepatide have changed what rapid, medically supported weight loss looks like for millions of people. But the same appetite suppression that drives the weight loss also shrinks how much food — and how many nutrients — you're taking in each day. A growing body of research shows that a meaningful share of the weight lost on these drugs is lean tissue, not just fat, and that micronutrient gaps can appear within months of starting treatment. Here's what the evidence actually shows about protecting your muscle and your nutrient status while on a GLP-1.
Quick Facts
- Lean mass is part of the loss: reviews of GLP-1 trials estimate that lean tissue makes up roughly 25% or more of total weight lost, depending on the study and population.
- Protein needs go up, not down: research on weight loss during caloric restriction points to roughly 1.2–1.6 g of protein per kilogram of body weight per day to help protect muscle.
- Resistance training offsets most of the loss: trials combining resistance exercise with a calorie deficit show it can preserve the large majority of lean mass that would otherwise be lost.
- Eating less means fewer nutrients, too: reduced appetite and food variety are linked to lower intakes of iron, vitamin B12, vitamin D, calcium, and thiamine in people on GLP-1 therapy.
- The pattern isn't fixed: in the SEMALEAN cohort, lean mass loss was concentrated in the first months of treatment and stabilized afterward, suggesting the trajectory can be influenced by diet and activity.
Why GLP-1 Medications Change What Your Body Needs
GLP-1 receptor agonists slow gastric emptying and act on appetite centers in the brain, which is exactly why they work so well for weight loss — people simply eat less. The problem is that "eating less" doesn't selectively cut calories; it cuts protein, fiber, vitamins, and minerals right along with them. Unlike bariatric surgery, GLP-1 drugs don't physically block nutrient absorption, but the practical effect on intake can look surprisingly similar, which is why clinicians increasingly borrow post-bariatric nutrition guidance when counseling patients on these medications.
At the same time, weight loss itself — regardless of method — puts muscle at risk if the body isn't given a reason to keep it. Skeletal muscle is metabolically "expensive" to maintain, and in a sustained calorie deficit the body will break some of it down for energy unless resistance is placed on those muscles and enough protein is available to rebuild them. This is where targeted support, including compounds like creatine monohydrate, is increasingly discussed alongside GLP-1 therapy.
Muscle Preservation: Protein, Resistance Training, and Creatine
The two interventions with the strongest evidence for preserving lean mass during weight loss are boring but effective: eat enough protein, and challenge your muscles regularly. A 2024 review in Diabetes, Obesity and Metabolism concluded that structured resistance training and adequate protein intake are the leading strategies for mitigating GLP-1-associated lean mass loss, and separate randomized trials in older adults losing weight found that combining a higher-protein diet with resistance exercise preserved fat-free mass far better than diet alone.
Creatine monohydrate is one of the most studied compounds for supporting muscle mass and strength during resistance training, and its role during intentional, medication-assisted weight loss is an active area of clinical interest, even though direct trials in GLP-1 users are still limited. Magnesium also supports normal muscle and nerve function and is one of the minerals most commonly under-consumed when overall food intake drops.
The Micronutrients Most at Risk
When appetite drops and meals shrink, the first casualties are usually foods that take effort to eat: red meat, leafy greens, dairy, and fortified grains. That pattern lines up with the deficiencies researchers are flagging most often in GLP-1 users — iron, vitamin B12, vitamin D, calcium, and thiamine. Vitamin B12 is particularly worth watching if animal-protein intake drops sharply, since plant foods contain very little of it naturally.
None of this means GLP-1 therapy causes malabsorption — it doesn't, in the way bariatric surgery can. The risk is almost entirely about volume: simply not eating enough of a wide enough range of foods to meet baseline needs, which is a solvable problem with some planning.
What the Evidence Actually Shows
GLP-1 therapies cause meaningful lean mass loss during rapid weight loss. Evidence level: Well-established. Multiple clinical reviews and trials, including body-composition sub-studies of major semaglutide and tirzepatide trials, consistently find that a notable portion of total weight lost on these drugs is lean tissue rather than fat.
Adequate protein intake helps offset lean mass loss during a calorie deficit. Evidence level: Well-established. Randomized controlled trials in people losing weight, including older adults, show that higher protein intakes (generally 1.2–1.6 g/kg/day) preserve significantly more fat-free mass than standard-protein diets.
Resistance training preserves the large majority of lean mass otherwise lost during weight loss. Evidence level: Well-established. Meta-analyses of controlled trials in adults undergoing caloric restriction show resistance exercise offsets most of the lean-mass loss seen with diet alone.
Micronutrient deficiencies are common in the first year of GLP-1 treatment. Evidence level: Promising. Clinical observations and nutrition-guidance reviews report frequent gaps in iron, B12, vitamin D, calcium, and thiamine, though large-scale, long-term deficiency-tracking studies specific to GLP-1 users are still developing.
Creatine supplementation directly offsets GLP-1-associated muscle loss. Evidence level: Mechanistically plausible but untested. Creatine's muscle-support effects are well documented in general resistance-training contexts, but dedicated trials testing it specifically in people on GLP-1 medications have not yet been published in large numbers.
How to Protect Your Muscle and Nutrient Status
Set a daily protein target and spread it out
Aim for roughly 1.2–1.6 g of protein per kilogram of your goal or current body weight, split across meals rather than loaded into one sitting. On a reduced appetite, this often means prioritizing protein first at each small meal — eggs, yogurt, fish, poultry, tofu, or a protein shake — before filling remaining space with vegetables and whole grains.
Add resistance training two to three times a week
You don't need a bodybuilding program. Two to three sessions a week hitting the major muscle groups — legs, back, chest, shoulders, core — using bodyweight, bands, or weights is enough, per the trial evidence, to preserve a large share of lean mass that would otherwise be lost to the calorie deficit.
Make small meals count nutritionally
When you can only manage small portions, choose nutrient-dense options over low-effort, low-nutrient ones: a piece of fruit and a hard-boiled egg beats crackers; a small portion of salmon beats a plain bagel. Fortified foods (cereals, plant milks) can help close gaps in iron, B12, and vitamin D without requiring larger volumes.
Talk to your prescriber about targeted supplementation
A basic multivitamin, along with individually assessed vitamin B12 and magnesium status, is a reasonable starting conversation with your doctor or dietitian, especially if bloodwork shows a gap or you've noticeably cut back on animal foods, dairy, or whole grains.
Safety and Who Should Be Cautious
Anyone starting or currently taking a GLP-1 medication should discuss nutrition and supplementation with the clinician managing their treatment, particularly because GI side effects (nausea, constipation, reflux) are common and can affect how well certain supplements are tolerated. People with a history of disordered eating, pregnant or breastfeeding individuals, and anyone with kidney disease should be especially careful with high-protein targets or new supplements without medical guidance, since protein and mineral needs and tolerances shift in those situations.
ⓘ Nutrient and supplement needs on GLP-1 therapy should be personalized with bloodwork, not guessed at. Ask your prescriber about baseline and follow-up labs for B12, iron/ferritin, and vitamin D if you'll be on treatment for more than a few months.
Frequently Asked Questions
Do I need a multivitamin while on a GLP-1 medication like semaglutide or tirzepatide?
Not automatically, but it's a reasonable, low-risk starting point if your food intake has dropped significantly, and many clinicians recommend one as a baseline safety net during active weight loss on these medications.
Why am I losing muscle even though I'm "just" losing weight?
Any significant weight loss, from any method, includes some lean tissue loss unless you actively counter it with adequate protein and resistance training — GLP-1s aren't unique in this, they just produce faster, larger total weight loss, which makes the lean-mass portion more noticeable.
How much protein do I actually need each day?
Most research on preserving muscle during weight loss points to roughly 1.2–1.6 grams of protein per kilogram of body weight daily, though your prescriber or a dietitian can help set an exact target based on your kidney function and goals.
Can creatine help while I'm on a GLP-1 medication?
Creatine has strong general evidence for supporting muscle mass and strength alongside resistance training; its specific use during GLP-1 therapy is promising but not yet backed by large dedicated trials, so treat it as a plausible add-on rather than a proven fix.
Should I stop supplements before a dose change or procedure?
Always tell your prescribing clinician about every supplement you're taking, especially before any dose adjustment, surgery, or new medication, so they can flag any interactions or timing changes specific to your situation.
Scientific References
- Wilding JPH, Batterham RL, Calanna S, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021.
- Neeland IJ, Linge J, Birkenfeld AL. "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Diabetes, Obesity and Metabolism, 2024.
- Alissou M, Demangeat T, Folope V, et al. "Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study." Diabetes, Obesity and Metabolism, 2025.
- "Bridging the nutrition guidance gap for GLP-1 receptor agonist therapy-assisted weight loss: lessons from bariatric surgery." International Journal of Obesity, 2025.
- Verreijen AM, Engberink MF, Memelink RG, van der Plas SE, Visser M, Weijs PJM. "Effect of a high protein diet and/or resistance exercise on the preservation of fat free mass during weight loss in overweight and obese older adults: a randomized controlled trial." Nutrition Journal, 2017.
- "Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis." Metabolism: Clinical and Experimental, 2024.
Disclaimer
This article is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. GLP-1 medications are prescription drugs that require medical supervision, and any changes to your diet, exercise, or supplement routine while taking one should be discussed with your prescribing physician or a registered dietitian. Individual nutrient needs vary based on health history, kidney function, pregnancy status, and other medications. LIVV100® products are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease.
